Bridgewater Associates’s Rayonier RYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-43,978
Closed -$907K 1152
2026
Q1
$907K Buy
+43,978
New +$969K ﹤0.01% 804
2025
Q4
Sell
-39,779
Closed -$1.01M 1163
2025
Q3
$1.01M Buy
+39,779
New +$954K ﹤0.01% 850
2023
Q1
Sell
-37,468
Closed -$1.12M 870
2022
Q4
$1.12M Buy
+37,468
New +$1.15M 0.01% 630
2022
Q3
Sell
-23,675
Closed -$803K 997
2022
Q2
$803K Buy
23,675
+1,957
+9% +$71.7K ﹤0.01% 830
2022
Q1
$810K Buy
21,718
+7,356
+51% +$261K ﹤0.01% 827
2021
Q4
$526K Buy
+14,362
New +$499K ﹤0.01% 640
2013
Q3
Sell
-7,232
Closed -$271K 394
2013
Q2
$271K Buy
+7,232
New +$280K ﹤0.01% 296

Other funds holding RYN

Bridgewater Associates's RYN Position: Q2 2026 in Review

Bridgewater Associates sold out of Rayonier (RYN) in Q2 2026, closing a stake of 43,978 shares — an estimated $907K sold.

Bridgewater Associates first reported a position in RYN in Q2 2013 and held it in 7 quarters. The position peaked at $1.12M in Q4 2022. 456 funds tracked by Wall St. Rank hold RYN as of Q2 2026.

  • Bridgewater Associates reported no remaining Rayonier position as of Q2 2026 after selling out during the quarter.
  • Bridgewater Associates sold 43,978 Rayonier shares in Q2 2026, an estimated $907K.
  • Bridgewater Associates first reported a position in Rayonier in Q2 2013 and held it in 7 quarters.
  • Bridgewater Associates's Rayonier position peaked at $1.12M in Q4 2022.
  • 456 funds tracked by Wall St. Rank held Rayonier as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.